TriMas (TRS) Q4 2023 earnings summary

Executive summary

• Q4 sales rose 3.1% YoY to $209.6M, with Packaging and Aerospace growth offsetting weaker Specialty Products demand; Segment Adjusted EBITDA was $41.3M, or 19.7% of sales.

• FY2023 sales increased 1.1% to $893.6M, while reported operating profit and net income declined; prior-year property-sale gains affected comparisons.

• FY2024 guidance anticipated 5%–8% sales growth and $1.95–$2.15 Adjusted diluted EPS; Specialty Products demand was expected to strengthen in H2.

Financial highlights

• Q4 operating profit was $11.6M versus $26.3M; Adjusted operating profit was $18.8M versus $36.3M, including a $17.6M prior-year property-divestiture gain that did not recur.

• Q4 net income was $7.9M, or $0.19 diluted EPS, versus $18.8M, or $0.45; Adjusted net income was $12.3M and Adjusted diluted EPS was $0.37 versus $0.62.

• FY2023 operating profit was $65.4M versus $99.1M; Adjusted operating profit was $89.5M versus $116.2M, down 4.6% excluding 2022 property-sale gains.

• FY2023 net income was $40.4M, or $0.97 diluted EPS, versus $66.2M, or $1.56; Adjusted net income was $59.1M and Adjusted diluted EPS was $1.74 versus $2.12.

• FY Adjusted EBITDA was $156.4M versus $178.0M in 2022, or $155.6M after adjusting for prior-year property gains.

Outlook and guidance

• FY2024 sales growth guidance was 5%–8%; Adjusted diluted EPS guidance was $1.95–$2.15, including announced acquisitions.

• Beginning Q1 2024, non-cash stock compensation would be added back in Adjusted diluted EPS; comparable 2023 Adjusted EPS was $1.92 after a $0.18 after-tax adjustment.

• Expected trends included modest Packaging recovery and strong Aerospace demand; Specialty Products demand was expected to be lower in H1 and strengthen in H2.

• Segment outlook: Packaging sales growth 5%–9% and Adjusted EBITDA margin 21.5%–23.5%; Aerospace growth 14%–18% and margin 16%–18%; Specialty Products growth -4%–1% and margin 17%–19%.

• FY2024 free cash flow was expected to increase 20%; enterprise assumptions included a 23%–25% tax rate and $17M interest expense.